BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7751626)

  • 1. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response.
    Lucas PJ; Negishi I; Nakayama K; Fields LE; Loh DY
    J Immunol; 1995 Jun; 154(11):5757-68. PubMed ID: 7751626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
    Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
    J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CTLA-4 in regulating Th2 differentiation.
    Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
    J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
    Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
    J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated mature T lymphocyte death.
    Boehme SA; Zheng L; Lenardo MJ
    J Immunol; 1995 Aug; 155(4):1703-12. PubMed ID: 7636229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28/B7 costimulation.
    Teh HS; Teh SJ
    Cell Immunol; 1997 Jul; 179(1):74-83. PubMed ID: 9259774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J
    J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo.
    Vella AT; Mitchell T; Groth B; Linsley PS; Green JM; Thompson CB; Kappler JW; Marrack P
    J Immunol; 1997 May; 158(10):4714-20. PubMed ID: 9144484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.
    Finn PW; He H; Wang Y; Wang Z; Guan G; Listman J; Perkins DL
    J Immunol; 1997 May; 158(9):4074-81. PubMed ID: 9126965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.
    Croft M; Joseph SB; Miner KT
    J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.